Home Education Hub Publications
Clinical Trial Management
Contract Development and Manufacturing
Decentralized Clinical Trials
European Medicines Agency
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Outsourcing Clinical Trials
Rare Disease Trials
Research & Development
Research and Development
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain
Discover how companies’ target prices are impacted by the different variables leveraged during the P&R process for oncology and oncohematology’s first indication.
White Paper: Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective
In this white paper, we will explore wide range of new therapies we term “Next Generation Therapies” and challenges related to them.
Real-World Evidence: Five Facts You Need to Know
Learn more about RWD and its future challenges for Europe, we asked Romain Finas, Vice President of Real-World Evidence (RWE) at Alira Health, to share five facts that you need to know about it.
Early Access Programs: Keys to Success
Discover Alira Health’s top five recommendations to building a successful Early Access Programs (EAP).
Next Generation Therapies: Access, Pricing, and Challenges
Learn more about Next Generation Therapies that have the potential to disrupt the biopharmaceutical environment.
Trend Outlook: Fostering Innovation and the Importance of Market Access
Interview with Robert Fabregat, CEO of Biocat, and Chus Castillo, Director of Global Market Access at Alira Health, to understand how companies can foster innovation locally and globally,(...)
White Paper: Enhancing Patient Access with Early Access Programs
Pharmaceutical companies are facing an increasing demand from physicians for Early Access Programs (EAPs) and are willing to make their innovative medicines available to patients with(...)
Alira Health Published in Business Development & Licensing Journal
Experts from the Alira Health team recently shared their thoughts regarding the importance of market access insights for the success of licensing operations with professionals from(...)
Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market
A health economics evaluation assists companies during product development to better understand the product's impact across the ecosystem and position it appropriately.
Critical Success Factors in Market Access
Today’s MedTech market is more concentrated than ever, with critical factors that need to be examined to advance a new product.
WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies
The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden(...)
Our Parallel Trade Expertise
Alira Health is proud to announce our new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.
Assessment of POCT Device Potential and Definition of a Go -To- Market Strategy for Selected Countries in South America
When our client, an Asia-based medtech company with a novel POCT solution, wanted to understand the best market access strategy to enter into Latin America, Alira Health shed light(...)
Latest from Alira Health
The State of Market Access in Italy 2023
To learn about the state of market access in Italy today, we spoke with Giovanni Firenze, Director of Market Access Italy for Alira Health, who attended the recent 2023 Conferenza Nazionale(...)
Diversity in Clinical Trials: A Blog Series
How can you successfully engage with patients from diverse populations? To gain the latest insights on the impact, challenges, and strategies, we are pleased to bring you a new series(...)
How Can Clinical Trials be More Inclusive?
Working with patients and patient leaders early and often can help life science companies to advance the mission of diversifying clinical trials and ultimately, bringing products to(...)
MGFA National Patient Conference 2023
We are pleased to share that we will be participating in MGFA National Patient Conference 2023 as speakers and exhibitors.
WIRED Health 2023
We are pleased to share that we will be attending and speaking at WIRED Health 2023. WIRED Health highlights the most exciting, thought-provoking disruptors scientists and practitioners(...)
World EPA Congress 2023
We are pleased to share that we will be participating in World EPA Congress 2023 as speakers and sponsors. World Evidence, Pricing and Access Congress is Europe’s largest congress(...)
MedTech CDMO: Market and M&A Trends in the U.S. in 2023
Join us for this exciting webinar to learn about the current trends shaping the US medical device outsourcing landscape, with a particular focus on its performance and business outlook,(...)
The MedTech World Podcast: Interview with Gabriele Brambilla
Gabriele Brambilla, CEO of Alira Health, has joined the MedTech World Podcast to discuss his experiences and journey in the Healthcare industry.
Introduction to Patient Engagement in MedTech in the U.S.
Watch this webinar to discover how the MedTech industry can successfully incorporate patient engagement activities at each stage of the medical device and diagnostic development product lifecycle.
Alira Health Partners with MedTech Innovator to Help Accelerate Startup Growth
Alira Health is pleased to partner with MedTech Innovator on their joint mission to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system.
Silicon Valley Bank Leads Group of Sponsors Funding LabCentral Ignite Programs to Support Underrepresented Life Sciences Entrepreneurs
Silicon Valley Bank has assembled a diverse group of organizations, including Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health, to sponsor LabCentral Ignite, a first-and-only-of-its-kind(...)
Access and reimbursement pathways for digital health solutions and in vitro diagnostic devices: Current scenario and challenges
Digital therapeutics (DTx) are innovative solutions that use meaningful data to provide evidence-based decisions for the prevention, treatment, and management of diseases. Particular(...)
Subscribe to our newsletter for the latest news, events, and thought leadership